These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8532435)

  • 1. Intradermal hepatitis B vaccination: five-year follow-up.
    Leonardi S; Barone P; Musumeci S
    Pediatr Infect Dis J; 1995 Aug; 14(8):716-7. PubMed ID: 8532435
    [No Abstract]   [Full Text] [Related]  

  • 2. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
    Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis B vaccination in patients on chronic hemodialysis].
    Kovacić V; Sain M; Vukman V
    Lijec Vjesn; 2003; 125(5-6):156-8. PubMed ID: 14533468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.
    Morais EO; Resende MR; Oliveira AM; Sinkoc VM; Garcia MT; Angerami RN; da Silva LJ
    Aliment Pharmacol Ther; 2007 Apr; 25(7):849-55. PubMed ID: 17373924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B vaccination in young nurses of a general hospital.
    Barone P; Sciacca A; Lupo F; Leonardi S; Musumeci S
    Ann Ig; 1995; 7(4):251-5. PubMed ID: 8679165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An early-type hypersensitivity (ETH) to hepatitis B surface antigen as a quick and economic screening test for a vaccination program.
    Barone P; Leonardi S; Oggiano R; Musumeci S
    Ann Ig; 1998; 10(2):121-4. PubMed ID: 9658674
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Active vaccination against hepatitis-B virus infection in thalassemia].
    Goldfarb A; Shouval S; Mani N; Shraga S; Rachmilewitz E
    Harefuah; 1986 Nov; 111(10):273-7. PubMed ID: 2950034
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intradermal hepatitis B vaccination in workers not responsive to intramuscular vaccination].
    Bauer H; Potasman I; Pick N
    Harefuah; 1998 Mar; 134(6):441-4, 503. PubMed ID: 10909572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
    Sorkhi H; Dooki MR; Ebrahimnejad MS
    J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose intramuscular hepatitis B vaccination in medical students: 4-year follow-up.
    Erensoy S; Bilgiç A; Arda B; Ozer O
    Infection; 2002 Oct; 30(5):303-5. PubMed ID: 12382091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary high-dose intradermal hepatitis B vaccination in hemodialysis: cost-effectiveness evaluation at 2 years.
    Mat O; Mestrez F; Beauwens R; Muniz-Martinez MC; Dhaene M
    Hemodial Int; 2006 Jan; 10(1):49-55. PubMed ID: 16441827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term efficacy of vaccination against hepatitis B in newborns: 13 years' follow-up].
    Wu W; Sun C; Jiang M; Xu Y; Zhang GH; Liu CB; Cao HL; Lin XM; Xu ZY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):239-41. PubMed ID: 11986695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
    Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
    J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of anti-HBV vaccine efficacy given intradermally and intramuscularly in hemodialysis patients].
    Miłkowski A; Wyrwicz G; Kubit P; Smoleński O
    Przegl Lek; 2000; 57(11):628-34. PubMed ID: 11293210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B revaccination in healthy non-responder Chinese children: five-year follow-up of immune response and immunologic memory.
    Zhuang GH; Yan H; Wang XL; Hwang LY; Wu Q; Wang LR; Gao HY
    Vaccine; 2006 Mar; 24(12):2186-92. PubMed ID: 16310902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rapid vaccination protocol against hepatitis B in patients with chronic kidney failure].
    Teruel JL; Fernández Lucas M; Mateos ML; Ortuño J
    Nefrologia; 2005; 25(3):338-9. PubMed ID: 16053018
    [No Abstract]   [Full Text] [Related]  

  • 19. [Non- and low-response after preventive hepatitis B vaccination].
    Hasselhorn HM; Kralj N; Hofmann F; Nübling M; Berthold H
    Gesundheitswesen; 1997 May; 59(5):321-8. PubMed ID: 9289224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
    Chen H; Zhu QR
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.